valdecoxib (Bextra)

08/01/2004 - "Pain scores on the mBPI-SF indicated significantly greater pain relief with valdecoxib at each assessment (all, P < or = 0.014 vs placebo). "
08/01/2004 - "No statistically significant differences in patient baseline characteristics were noted between treatment groups, except in response to 1 mBPI-SF question; patients in the valdecoxib group reported significantly greater interference in relations with other people due to pain than did those in the placebo group (P = 0.048). "
01/01/2002 - "Pain intensity levels and patient satisfaction were significantly improved in both valdecoxib groups compared with placebo. "
01/01/2004 - "Pre-emptive administration of valdecoxib 10-80 mg was particularly effective in dental pain. "
09/01/2006 - "Two randomized, double-blind, placebo-controlled studies assessed the analgesic efficacy of valdecoxib in patients with moderate-to-severe pain after bunionectomy. "

06/01/2007 - "Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study."
02/15/2003 - "The analgesic efficacy of valdecoxib at a dose of 10 mg once daily in both osteoarthritis and rheumatoid arthritis is superior to that of placebo and similar to that of traditional non-steroidal anti-inflammatory drugs. "
10/01/2004 - "Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials."
07/01/2004 - "We evaluated cardiovascular event data for valdecoxib, a new COX-2-specific inhibitor in approximately 8000 patients with osteoarthritis and rheumatoid arthritis treated with this agent in randomized clinical trials. "
03/01/2005 - "Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis."

05/01/2007 - "Valdecoxib is a non-steroidal anti-inflammatory drug used in the treatment of rheumatoid and osteoarthritis. "
02/15/2003 - "The analgesic efficacy of valdecoxib at a dose of 10 mg once daily in both osteoarthritis and rheumatoid arthritis is superior to that of placebo and similar to that of traditional non-steroidal anti-inflammatory drugs. "
10/01/2004 - "Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials."
07/01/2004 - "We evaluated cardiovascular event data for valdecoxib, a new COX-2-specific inhibitor in approximately 8000 patients with osteoarthritis and rheumatoid arthritis treated with this agent in randomized clinical trials. "
03/01/2005 - "Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis."

09/01/2006 - "Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy."
09/01/2006 - "Valdecoxib for postoperative pain management after cesarean delivery: a randomized, double-blind, placebo-controlled study."
09/01/2002 - "Preoperative orally administered valdecoxib provides well-tolerated and effective analgesia for mild to moderate postoperative pain."
07/01/2006 - "Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies."
07/01/2003 - "Parecoxib, a prodrug of valdecoxib, a selective COX-2 inhibitor, has been recently introduced for the treatment of moderate to severe postoperative pain. "

08/01/2002 - "Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea."
01/01/2005 - "Valdecoxib was effective and well tolerated and thus appears to be a viable treatment for menstrual pain due to primary dysmenorrhea."
01/01/2005 - "Valdecoxib for treatment of primary dysmenorrhea. "
08/01/2002 - "Both valdecoxib 20- and 40-mg doses were effective and well tolerated for the treatment of primary dysmenorrhea. "
02/15/2003 - "Valdecoxib is effective in single doses of up to 40 mg for the alleviation of acute menstrual pain and has a rapid onset of action (within 30 min) and a long duration of analgesia (up to 24 h). "